Deep learning in pharmacogenomics: from gene regulation to patient stratification

References

• 1 Obermeyer Z, Emanuel EJ. Predicting the future – big data, machine learning, and clinical medicine. N. Engl. J. Med. 375(13), 1216–1219 (2016).
  MedlineGoogle Scholar
• 2 Dinov ID. Methodological challenges and analytic opportunities for modeling and interpreting big healthcare data. Gigascience 5, 12 (2016).
  MedlineGoogle Scholar
• 3 Belle A, Thiagarajan R, Soroushmehr SM, Navidi F, Beard DA, Najarian K. Big data analytics in healthcare. Biomed Res. Int. 2015, 370194 (2015).
  MedlineGoogle Scholar
• 4 Halevy A, Norvig P, Pereira F. The unreasonable effectiveness of data. IEEE Intell. Syst. 24(2), 8–12 (2009).
  Google Scholar
• 5 Lecun Y, Bengio Y, Hinton G. Deep learning. Nature 521(7553), 436–444 (2015).
  Medline CASGoogle Scholar
• 6 Leung MKK, Delong A, Alipanahi B, Frey BJ. Machine learning in genomic medicine: a review of computational problems and datasets. Proc. IEEE 104(1), 176–197 (2016).
  Google Scholar
• 7 Angermueller C, Parnamaa T, Parts L, Stegle O. Deep learning for computational biology. Mol. Syst. Biol. 12(7), 878 (2016).
  MedlineGoogle Scholar
• 8 Ching T, Himmelstein DS, Beaulieu-Jones BK et al. Opportunities and obstacles for deep learning in biology and medicine. J. R. Soc. Interface 15(141), pii:20170387 (2018).
  MedlineGoogle Scholar
• 9 Patel JN. Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives. Pharmgenomics Pers. Med. 9, 65–77 (2016).
  Medline CASGoogle Scholar
• 10 Smith RM. Advancing psychiatric pharmacogenomics using drug development paradigms. Pharmacogenomics 18(15), 1459–1467 (2017).
  CASGoogle Scholar
• 11 Adams SM, Conley YP, Wagner AK et al. The pharmacogenomics of severe traumatic brain injury. Pharmacogenomics 18(15), 1413–1425 (2017).
  CASGoogle Scholar
• 12 Cavallari LH, Weitzel K. Pharmacogenomics in cardiology – genetics and drug response: 10 years of progress. Future Cardiol. 11(3), 281–286 (2015).
  CASGoogle Scholar
• 13 Filipski KK, Pacanowski MA, Ramamoorthy A, Feero WG, Freedman AN. Dosing recommendations for pharmacogenetic interactions related to drug metabolism. Pharmacogenet. Genomics 26(7), 334–339 (2016).
  Medline CASGoogle Scholar
• 14 Dopazo J. Genomics and transcriptomics in drug discovery. Drug Discov. Today 19(2), 126–132 (2014).
  Medline CASGoogle Scholar
• 15 Biankin AV, Piantadosi S, Hollingsworth SJ. Patient-centric trials for therapeutic development in precision oncology. Nature 526(7573), 361–370 (2015).
  Medline CASGoogle Scholar
• 16 Rosenblat JD, Lee Y, McIntyre RS. Does pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost–effectiveness studies. J. Clin. Psychiatry 78(6), 720–729 (2017).
  MedlineGoogle Scholar
• 17 Roadmap Epigenomics Consortium; Kundaje A, Meuleman W et al. Integrative analysis of 111 reference human epigenomes. Nature 518(7539), 317–330 (2015).
  MedlineGoogle Scholar
• 18 Higgins GA, Allyn-Feuer A, Handelman S, Sadee W, Athey BD. The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomics. Pharmacogenomics 16(14), 1649–1669 (2015).
  CASGoogle Scholar
• 19 Harper AR, Topol EJ. Pharmacogenomics in clinical practice and drug development. Nat. Biotechnol. 30(11), 1117–1124 (2012).
  Medline CASGoogle Scholar
• 20 Nemutlu E, Zhang S, Juranic NO, Terzic A, Macura S, Dzeja P. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases. Croat. Med. J. 53(6), 529–534 (2012).
  Medline CASGoogle Scholar
• 21 Husain SS, Kalinin A, Truong A, Dinov ID. SOCR data dashboard: an integrated big data archive mashing medicare, labor, census and econometric information. J. Big Data 2, pii:13 (2015).
  MedlineGoogle Scholar
• 22 Kalinin AA, Palanimalai S, Dinov ID. SOCRAT platform design: a web architecture for interactive visual analytics applications. In: Proceedings of the 2nd Workshop on Human-In-the-Loop Data Analytics. ACM New York, NY, USA, 1–6 (2017).
  Google Scholar
• 23 Fan J, Liu H. Statistical analysis of big data on pharmacogenomics. Adv. Drug Deliv. Rev. 65(7), 987–1000 (2013).
  Medline CASGoogle Scholar
• 24 Li R, Kim D, Ritchie MD. Methods to analyze big data in pharmacogenomics research. Pharmacogenomics 18(8), 807–820 (2017).
  CASGoogle Scholar
• 25 Vidyasagar M. Identifying predictive features in drug response using machine learning: opportunities and challenges. Annu. Rev. Pharmacol. 55, 15–34 (2015).
  CASGoogle Scholar
• 26 Lever J, Krzywinski M, Altman N. Points of significance: classification evaluation. Nat. Methods 13(8), 603–604 (2016).
  CASGoogle Scholar
• 27 Mamoshina P, Vieira A, Putin E, Zhavoronkov A. Applications of deep learning in biomedicine. Mol. Pharm. 13(5), 1445–1454 (2016).
  Medline CASGoogle Scholar
• 28 Baskin Ii, Winkler D, Tetko IV. A renaissance of neural networks in drug discovery. Expert Opin. Drug Discov. 11(8), 785–795 (2016).
  Medline CASGoogle Scholar
• 29 Gawehn E, Hiss JA, Schneider G. Deep learning in drug discovery. Mol. Inform. 35(1), 3–14 (2016).
  Medline CASGoogle Scholar
• 30 Goh GB, Hodas NO, Vishnu A. Deep learning for computational chemistry. J. Comput. Chem. 38(16), 1291–1307 (2017).
  Medline CASGoogle Scholar
• 31 Ramsundar B, Liu B, Wu Z et al. Is multitask deep learning practical for pharma? J. Chem. Inf. Model. 57(8), 2068–2076 (2017).
  Medline CASGoogle Scholar
• 32 Pérez-Sianes J, Pérez-Sánchez H, Díaz F. Virtual screening: a challenge for deep learning. In: 10th International Conference on Practical Applications of Computational Biology & Bioinformatics. Mohamad MS, Rocha MP, Fdez-Riverola F, Domínguez-Mayo FJ, De Paz JF (Eds). Springer International Publishing, Cham, Switzerland, 13–22 (2016).
  Google Scholar
• 33 Litjens G, Kooi T, Bejnordi BE et al. A survey on deep learning in medical image analysis. Med. Image Anal. doi:10.1016/j.media.2017.07.005 (2017).
  Google Scholar
• 34 Iglovikov V, Rakhlin A, Kalinin A, Shvets A. Pediatric bone age assessment using deep convolutional neural networks. arXiv 1712.05053 (2017).
  Google Scholar
• 35 Rakhlin A, Shvets A, Iglovikov V, Kalinin AA. Deep convolutional neural networks for breast cancer histology image analysis. arXiv 1802.00752 (2018).
  Google Scholar
• 36 Shvets A, Rakhlin A, Kalinin A, Iglovikov V. Automatic instrument segmentation in robot-assisted surgery using deep learning. bioRxiv doi:10.1101/275867 (2018).
  Google Scholar
• 37 Liang M, Li Z, Chen T, Zeng J. Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach. IEEE/ACM Trans. Comput. Biol. Bioinform. 12(4), 928–937 (2015).
  Medline CASGoogle Scholar
• 38 Chaudhary K, Poirion OB, Lu L, Garmire LX. Deep learning based multi-omics integration robustly predicts survival in liver cancer. Clin. Cancer Res. doi:10.1158/1078-0432.CCR-17-0853 (2017).
  MedlineGoogle Scholar
• 39 Aliper A, Plis S, Artemov A, Ulloa A, Mamoshina P, Zhavoronkov A. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol. Pharm. 13(7), 2524–2530 (2016).
  Medline CASGoogle Scholar
• 40 Beaulieu-Jones BK, Greene CS; Pooled Resource Open-Access ALSCTC. Semi-supervised learning of the electronic health record for phenotype stratification. J. Biomed. Inform. 64, 168–178 (2016).
  MedlineGoogle Scholar
• 41 Kelley DR, Snoek J, Rinn JL. Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks. Genome Res. 26(7), 990–999 (2016).
  Medline CASGoogle Scholar
• 42 Wu Z, Ramsundar B, Feinberg Evan N et al. MoleculeNet: a benchmark for molecular machine learning. Chem. Sci. 9(2), 513–530 (2018).
  Medline CASGoogle Scholar
• 43 Lever J, Krzywinski M, Altman N. Points of significance: model selection and overfitting. Nat. Methods 13(9), 703–704 (2016).
  CASGoogle Scholar
• 44 Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE 10(3), e0118432 (2015).
  MedlineGoogle Scholar
• 45 Huang TH, Fan B, Rothschild MF, Hu ZL, Li K, Zhao SH. miRFinder: an improved approach and software implementation for genome-wide fast microRNA precursor scans. BMC Bioinformatics 8, 341 (2007).
  MedlineGoogle Scholar
• 46 Avati A, Jung K, Harman S, Downing L, Ng A, Shah NH. Improving palliative care with deep learning. arXiv 1711.06402 (2017).
  Google Scholar
• 47 Zhou J, Troyanskaya OG. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12(10), 931–934 (2015).
  Medline CASGoogle Scholar
• 48 Alipanahi B, Delong A, Weirauch MT, Frey BJ. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning. Nat. Biotechnol. 33(8), 831–838 (2015).
  Medline CASGoogle Scholar
• 49 Umarov RK, Solovyev VV. Recognition of prokaryotic and eukaryotic promoters using convolutional deep learning neural networks. PLoS ONE 12(2), e0171410 (2017).
  MedlineGoogle Scholar
• 50 Shrikumar A, Greenside P, Kundaje A. Learning important features through propagating activation differences. Proceedings of the 34th International Conference on Machine Learning. Sydney, Australia, 6–11 August 2017.
  Google Scholar
• 51 Lanchantin J, Singh R, Wang B, Qi Y. Deep motif dashboard: visualizing and understanding genomic sequences using deep neural networks. Pac. Symp. Biocomput. 22, 254–265 (2016).
  Google Scholar
• 52 Deming L, Targ S, Sauder N, Almeida D, Ye CJ. Genetic architect: discovering genomic structure with learned neural architectures. arXiv 1605.07156 (2016).
  Google Scholar
• 53 Xu Y, Dai Z, Chen F, Gao S, Pei J, Lai L. Deep learning for drug-induced liver injury. J. Chem. Inf. Model. 55(10), 2085–2093 (2015).
  Medline CASGoogle Scholar
• 54 Quang D, Xie X. DanQ: a hybrid convolutional and recurrent deep neural network for quantifying the function of DNA sequences. Nucleic Acids Res. 44(11), e107 (2016).
  MedlineGoogle Scholar
• 55 Singh R, Lanchantin J, Robins G, Qi Y. DeepChrome: deep-learning for predicting gene expression from histone modifications. Bioinformatics 32(17), i639–i648 (2016).
  Medline CASGoogle Scholar
• 56 Qin Q, Feng JX. Imputation for transcription factor binding predictions based on deep learning. PLoS Comput. Biol. 13(2), e1005403 (2017).
  MedlineGoogle Scholar
• 57 Schreiber J, Libbrecht M, Bilmes J, Noble W. Nucleotide sequence and DNaseI sensitivity are predictive of 3D chromatin architecture. bioRxiv doi:10.1101/103614 (2017).
  Google Scholar
• 58 Zeng H, Gifford DK. Predicting the impact of non-coding variants on DNA methylation. Nucleic Acids Res. 45(11), e99 (2017).
  MedlineGoogle Scholar
• 59 Angermueller C, Lee HJ, Reik W, Stegle O. DeepCpG: accurate prediction of single-cell DNA methylation states using deep learning. Genome Biol. 18(1), 67 (2017).
  MedlineGoogle Scholar
• 60 Pan X, Shen HB. RNA-protein binding motifs mining with a new hybrid deep learning based cross-domain knowledge integration approach. BMC Bioinformatics 18(1), 136 (2017).
  MedlineGoogle Scholar
• 61 Pan X, Rijnbeek P, Yan J, Shen H-B. Prediction of RNA-protein sequence and structure binding preferences using deep convolutional and recurrent neural networks. bioRxiv doi:10.1101/146175 (2017).
  Google Scholar
• 62 Quang D, Xie X. FactorNet: a deep learning framework for predicting cell type specific transcription factor binding from nucleotide-resolution sequential data. bioRxiv doi:10.1101/151274 (2017).
  Google Scholar
• 63 Kelley DR, Reshef YA. Sequential regulatory activity prediction across chromosomes with convolutional neural networks. bioRxiv doi:10.1101/161851 (2017).
  Google Scholar
• 64 Avsec Z, Barekatain M, Cheng J, Gagneur J. Modeling positional effects of regulatory sequences with spline transformations increases prediction accuracy of deep neural networks. bioRxiv doi:10.1101/165183 (2017).
  Google Scholar
• 65 Hiranuma N, Lundberg S, Lee S-I. DeepATAC: a deep-learning method to predict regulatory factor binding activity from ATAC-seq signals. bioRxiv doi:10.1101/172767 (2017).
  Google Scholar
• 66 Higgins GA, Allyn-Feuer A, Athey BD. Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response. Pharmacogenomics 16(14), 1565–1583 (2015).
  CASGoogle Scholar
• 67 Higgins GA, Allyn-Feuer A, Barbour E, Athey BD. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis. Pharmacogenomics 16(14), 1547–1563 (2015).
  CASGoogle Scholar
• 68 Higgins GA, Georgoff P, Nikolian V et al. Network reconstruction reveals that valproic acid activates neurogenic transcriptional programs in adult brain following traumatic injury. Pharm. Res. 34(8), 1658–1672 (2017).
  Medline CASGoogle Scholar
• 69 Dekker J, Mirny L. The 3D genome as moderator of chromosomal communication. Cell 164(6), 1110–1121 (2016).
  Medline CASGoogle Scholar
• 70 Kalinin AA, Allyn-Feuer A, Ade A et al. 3D cell nuclear morphology: microscopy imaging dataset and voxel-based morphometry classification results. bioRxiv doi:10.1101/208207 (2017).
  Google Scholar
• 71 Zheng G, Kalinin AA, Dinov ID, Meixner W, Zhu S, Wiley JW. Rotational 3D mechanogenomic Turing patterns of human colon Caco-2 cells during differentiation. bioRxiv doi:10.1101/272096 (2018).
  Google Scholar
• 72 Higgins GA, Allyn-Feuer A, Georgoff P, Nikolian V, Alam HB, Athey BD. Mining the topography and dynamics of the 4D nucleome to identify novel CNS drug pathways. Methods 123, 102–118 (2017).
  Medline CASGoogle Scholar
• 73 Sanjana NE, Wright J, Zheng K et al. High-resolution interrogation of functional elements in the noncoding genome. Science 353(6307), 1545–1549 (2016).
  Medline CASGoogle Scholar
• 74 Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology 78(20), 1548–1554 (2012).
  Medline CASGoogle Scholar
• 75 Nishizaki SS, Boyle AP. Mining the unknown: assigning function to noncoding single nucleotide polymorphisms. Trends Genet. 33(1), 34–45 (2017).
  Medline CASGoogle Scholar
• 76 Park Y, Kellis M. Deep learning for regulatory genomics. Nat. Biotechnol. 33(8), 825–826 (2015).
  Medline CASGoogle Scholar
• 77 Min X, Zeng WW, Chen N, Chen T, Jiang R. Chromatin accessibility prediction via convolutional long short-term memory networks with k-mer embedding. Bioinformatics 33(14), I92–I101 (2017).
  Medline CASGoogle Scholar
• 78 Cao Z, Zhang S. gkm-DNN: efficient prediction using gapped k-mer features and deep neural networks. bioRxiv doi:10.1101/170761 (2017).
  Google Scholar
• 79 Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (7414), 57–74 (2012).
  MedlineGoogle Scholar
• 80 Kim SG, Harwani M, Grama A, Chaterji S. EP-DNN: a deep neural network-based global enhancer prediction algorithm. Sci. Rep. 6, 38433 (2016).
  Medline CASGoogle Scholar
• 81 Xu M, Ning C, Ting C, Rui J. DeepEnhancer: predicting enhancers by convolutional neural networks. Presented at: 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). Shenzen, China, 15–18 December 2016.
  Google Scholar
• 82 Liu F, Li H, Ren C, Bo X, Shu W. PEDLA: predicting enhancers with a deep learning-based algorithmic framework. Sci. Rep. 6, 28517 (2016).
  Medline CASGoogle Scholar
• 83 Singh S, Yang Y, Poczos B, Ma J. Predicting enhancer–promoter interaction from genomic sequence with deep neural networks. bioRxiv doi:10.1101/085241 (2016).
  Google Scholar
• 84 Jiyun Z, Qin L, Ruifeng X, Lin G, Hongpeng W. CNNsite: prediction of DNA-binding residues in proteins using convolutional neural network with sequence features. Presented at: 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). Shenzen, China, 15–18 December 2016.
  Google Scholar
• 85 Eser U, Churchman LS. FIDDLE: an integrative deep learning framework for functional genomic data inference. bioRxiv doi:10.1101/081380 (2016).
  Google Scholar
• 86 Poplin R, Newburger D, Dijamco J et al. Creating a universal SNP and small indel variant caller with deep neural networks. bioRxiv doi:10.1101/092890 (2018).
  Google Scholar
• 87 Carroll A, Thangaraj N. Evaluating DeepVariant: a new deep learning variant caller from the google brain team (2017). https://blog.dnanexus.com/2017-12-05-evaluating-deepvariant-googles-machine-learning-variant-caller/.
  Google Scholar
• 88 Uppu S, Krishna A. Improving Strategy for Discovering Interacting Genetic Variants in Association Studies. Springer, Cham, Switzerland, 461–469 (2016).
  Google Scholar
• 89 Uppu S, Krishna A, Gopalan RP. A deep learning approach to detect SNP interactions. J. Software 11(10), 965–975 (2016).
  Google Scholar
• 90 Food and Drug Administration. Clinical pharmacogenomics: premarket evaluation in early-phase clinical studies and recommendations for labeling. US Department of Health and Human Services, Silver Spring, MD, USA (2013).www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM337169.pdf.
  Google Scholar
• 91 Shickel B, Tighe P, Bihorac A, Rashidi P. Deep EHR: a survey of recent advances on deep learning techniques for electronic health record (EHR) analysis. arXiv 1706.03446 (2017).
  Google Scholar
• 92 Genomes Project C, Auton A, Brooks LD et al. A global reference for human genetic variation. Nature 526(7571), 68–74 (2015).
  MedlineGoogle Scholar
• 93 Miotto R, Weng C. Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials. J. Am. Med. Inform. Assoc. 22(e1), e141–e150 (2015).
  MedlineGoogle Scholar
• 94 Wei WQ, Denny JC. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med. 7(1), 41 (2015).
  MedlineGoogle Scholar
• 95 Kannry JL, Williams MS. Integration of genomics into the electronic health record: mapping terra incognita. Genet. Med. 15(10), 757–760 (2013).
  MedlineGoogle Scholar
• 96 Miotto R, Li L, Kidd BA, Dudley JT. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci. Rep. 6, 26094 (2016).
  Medline CASGoogle Scholar
• 97 Hwang U, Choi S, Yoon S. Disease prediction from electronic health records using generative adversarial networks. arXiv 1711.04126 (2017).
  Google Scholar
• 98 Che Z, Cheng Y, Zhai S, Sun Z, Liu Y. Boosting deep learning risk prediction with generative adversarial networks for electronic health records. arXiv 1709.01648 (2017).
  Google Scholar
• 99 Pham T, Tran T, Phung D, Venkatesh S. DeepCare: a deep dynamic memory model for predictive medicine. In: Advances in Knowledge Discovery and Data Mining: 20th Pacific-Asia Conference, PAKDD 2016, Auckland, New Zealand, April 19–22, 2016, Proceedings, Part II. Bailey J, Khan L, Washio T, Dobbie G, Huang JZ, Wang R (Eds). Springer International Publishing, Cham, Switzerland, 30–41 (2016).
  Google Scholar
• 100 Choi E, Bahadori MT, Schuetz A, Stewart WF, Sun J. Doctor AI: predicting clinical events via recurrent neural networks. In: Proceedings of the 1st Machine Learning for Healthcare Conference. Doshi-Velez F, Fackler J, Kale D, Wallace B, Wiens J (Eds). PMLR Children's Hospital LA, CA, USA, 301–318 (2016).
  Google Scholar
• 101 Beaulieu-Jones BK, Orzechowski P, Moore JH. Mapping patient trajectories using longitudinal extraction and deep learning in the MIMIC-III critical care database. In: Biocomputing 2018. Altman RB, Dunker AK, Hunter L, Ritchie MD, Murray TA, Klein TE (Eds). World Scientific, Singapore, 123–132 (2018).
  Google Scholar
• 102 Kale DC, Che Z, Bahadori MT, Li W, Liu Y, Wetzel R. Causal phenotype discovery via deep networks. AMIA Annu. Symp. Proc. 2015, 677–686 (2015).
  MedlineGoogle Scholar
• 103 Nemati S, Ghassemi MM, Clifford GD. Optimal medication dosing from suboptimal clinical examples: a deep reinforcement learning approach. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2016, 2978–2981 (2016).
  MedlineGoogle Scholar
• 104 Rajpurkar P, Hannun AY, Haghpanahi M, Bourn C, Ng AY. Cardiologist-level arrhythmia detection with convolutional neural networks. arXiv 1707.01836 (2017).
  Google Scholar
• 105 ResearchKit. http://researchkit.org/.
  Google Scholar
• 106 Mangravite L. Sage bionetworks in collaboration with The Michael J. Fox Foundation announce winners in the DREAM Parkinson's Disease Digital Biomarker Challenge (2018). www.businesswire.com/news/home/20180117006187/en/Sage-Bionetworks-Collaboration-Michael-J.-Fox-Foundation.
  Google Scholar
• 107 The Mood Challenge (2017). www.moodchallenge.com/.
  Google Scholar
• 108 Saint-Andre V, Federation AJ, Lin CY et al. Models of human core transcriptional regulatory circuitries. Genome Res. 26(3), 385–396 (2016).
  Medline CASGoogle Scholar
• 109 Ivanov M, Kals M, Kacevska M, Metspalu A, Ingelman-Sundberg M, Milani L. In-solution hybrid capture of bisulfite-converted DNA for targeted bisulfite sequencing of 174 ADME genes. Nucleic Acids Res. 41(6), e72 (2013).
  Medline CASGoogle Scholar
• 110 Hunter P, Coveney PV, De Bono B et al. A vision and strategy for the virtual physiological human in 2010 and beyond. Philos. Trans. A Math. Phys. Eng. Sci. 368(1920), 2595–2614 (2010).
  MedlineGoogle Scholar
• 111 Zhu F, Li XX, Yang SY, Chen YZ. Clinical success of drug targets prospectively predicted by in silico study. Trends Pharmacol. Sci. 339(3), 229–231 (2018).
  Google Scholar
• 112 Kadurin A, Aliper A, Kazennov A et al. The cornucopia of meaningful leads: applying deep adversarial autoencoders for new molecule development in oncology. Oncotarget 8(7), 10883–10890 (2017).
  MedlineGoogle Scholar
• 113 Kadurin A, Nikolenko S, Khrabrov K, Aliper A, Zhavoronkov A. druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico. Mol. Pharm. 14(9), 3098–3104 (2017).
  Medline CASGoogle Scholar
• 114 Blaschke T, Olivecrona M, Engkvist O, Bajorath J, Chen H. Application of generative autoencoder in de novo molecular design. Mol. Inform. 37(1–2), 1700123 (2017).
  Google Scholar
• 115 Altae-Tran H, Ramsundar B, Pappu AS, Pande V. Low data drug discovery with one-shot learning. ACS Cent. Sci. 3(4), 283–293 (2017).
  Medline CASGoogle Scholar
• 116 Wen M, Zhang Z, Niu S et al. Deep-learning-based drug-target interaction prediction. J. Proteome Res. 16(4), 1401–1409 (2017).
  Medline CASGoogle Scholar
• 117 Preuer K, Lewis RPI, Hochreiter S, Bender A, Bulusu KC, Klambauer G. DeepSynergy: predicting anticancer drug synergy with deep learning. Bioinformatics 34(9), 1538–1546 (2018).
  Medline CASGoogle Scholar
• 118 Mayr A, Klambauer G, Unterthiner T, Hochreiter S. DeepTox: toxicity prediction using deep learning. Front. Environ. Sci. doi.org/10.3389/fenvs.2015.00080 (2016).
  MedlineGoogle Scholar
• 119 Kearnes S, Goldman B, Pande V. Modeling industrial ADMET data with multitask networks. arXiv 1606.08793 (2016).
  Google Scholar
• 120 Xu Y, Pei J, Lai L. Deep learning based regression and multiclass models for acute oral toxicity prediction with automatic chemical feature extraction. J. Chem. Inf. Model. 57(11), 2672–2685 (2017).
  Medline CASGoogle Scholar
• 121 Sushko I, Salmina E, Potemkin VA, Poda G, Tetko IV. ToxAlerts: a web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. J. Chem. Inf. Model. 52(8), 2310–2316 (2012).
  Medline CASGoogle Scholar
• 122 Guo W, Xu YE, Feng X. DeepMetabolism: a deep learning system to predict phenotype from genome sequencing. bioRxiv doi:10.1101/135574 (2017).
  Google Scholar
• 123 Vougas K, Krochmal M, Jackson T et al. Deep learning and association rule mining for predicting drug response in cancer. A personalised medicine approach. bioRxiv doi:10.1101/070490 (2017).
  Google Scholar
• 124 Gao M, Igata H, Takeuchi A, Sato K, Ikegaya Y. Machine learning-based prediction of adverse drug effects: an example of seizure-inducing compounds. J. Pharmacol. Sci. 133(2), 70–78 (2017).
  Medline CASGoogle Scholar
• 125 Liang ZH, Huang JX, Zeng X, Zhang G. DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions. BMC Med. Genomics 9(Suppl. 2), 48 (2016).
  MedlineGoogle Scholar
• 126 Bughin J, Hazan E, Ramaswamy S et al. Artificial intelligence the next digital frontier? McKinsey and Company Global Institute (2017).www.mckinsey.com/∼/media/McKinsey/Industries/Advanced Electronics/Our Insights/How artificial intelligence can deliver real value to companies/MGI-Artificial-Intelligence-Discussion-paper.ashx.
  Google Scholar
• 127 Sullivan F. Bioinformatics and advanced analytics powering drug discovery (2017). www.researchandmarkets.com/reports/4308287/bioinformatics-and-advanced-analytics-powering.
  Google Scholar
• 128 Benhenda M. Outsourcing AI for drug discovery: independent expertise is key to avoid overhyped claims (2017). www.biopharmatrend.com/post/49-research-in-ai-for-drug-discovery-is-overhyped-and-what-to-do-about-it/.
  Google Scholar